N端脑钠肽前体检测在心力衰竭诊断中的应用(2)
第1页 |
参见附件。
参考文献
[1] Richards AM,Nicholls MG,Yandle TG,et alPlasm a N-terminal pro-brain natriuretic peptide and adrenomedull in new neurohormonal predictors of left ventricular dysfunction and prognosis after myocardial infarction[J].Circulation,1998;97(19): 1921-9
[2] Tang WH. B-type natriuretic peptide:a critical review[J].Congest Heart Fail,2007,13(1):48-52
[3] Ko c M,Bozkurt A,Yildiray-Sahin D,et al. Cutoff values of NT-proBNP for the prediction of low functional capacity,decreased ejection fraction and cardiovascular events in patients with heart failure [J]. Cardiol J,2009,16(1):43-49
[4] Azzazyhm,Christenson RH.DUH SH·Stability of B-type natriuretic peptide(BNP) in whole blood and plasma stored under diff erent conditions when measured with the Biosite Triage or Beckman-Coulter Access Systems[J].Clin Chim Acta,2007 384(1-2):176-178
[5] Ordonez-Llanos J,Collinson P O,Christenson R H.Aminotermina l pro-B-type natriuretic peptide:analytic considerations[J].Am JCardiol,2008,101(3A):9-15
[6] M acGowanGA, N eely D, Peaston R, et a.l Evaluation of NTProBNP to predict outcomes in advanced heart failure[ J].Int JClin Pract, 2010, 64( 7): 892-899
[7] Emdin M,Passino C,Prontera C,et a1.Comparison of brain natriuretic peptide (BNP) and amio-terminal proBNP for early diagnosis of heart failure[J].Clin Chemistry,2007,53(7):1289-1297
[8] 葛正中,吴永华,王晓周.血浆N端脑钠肽前体与老年慢性心力衰竭患者心功能的关系及其临床意义.实用老年医学,2010,24(6):463-465
您现在查看是摘要介绍页,详见PDF附件。